Adoptively transferred NK cells often have high levels of NKG2A+ NK cells and have been used to treat AML, and therefore SINEs may be an interesting combination for these studies in AML patients [107,108] (NCT00274846 and NCT01106950). The gene discussed is KLRC1; the disease is acute myeloid leukemia.